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We investigated the tissue-specific effects of dichlorody-
phenyltrichloroethane (DDT) isomers in adult and suckling
newborn mice, using a novel mouse line engineered to ex-
press a reporter of estrogen receptor transcriptional activity
(ERE-tkLUC mouse). The DDT isomers p,p’-DDT [1,1,1-tri-
chloro2,2-bis(p-chlorophenyl) ethane] and o,p’-DDT [1,1,1-tri-
chloro-2(p-chlorophenyl)-2-(o-chlorophenyl) ethane] were
specifically selected as a weak and a strong estrogen, respec-
tively. In adult male mice, p,p’-DDT induced luciferase activ-
ity in liver, brain, thymus, and prostate but not in heart and
lung. The effect of p,p’-DDT was dose-dependent, maximal at
16 h after sc treatment, and completely blocked by the estro-
gen receptor antagonist ICI-182,780. In all the organs ana-
lyzed, except the liver, administration of o,p’-DDT showed a
pattern of luciferase induction superimposable to that of its
isomer p,p’-DDT. In liver, o,p’-DDT significantly decreased
basal luciferase activity and blocked the reporter induction
by 17-estradiol. These data lead us to hypothesize that a
modulation of ER activity may be involved in the toxic effects
of DDT demonstrated by epidemiological and experimental
studies.
Luciferase activity was also studied in 4-d-old mice lactat-
ing from a mother injected with either p,p’-DDT or o,p’-DDT.
Both isomers induced a 2-fold increase in the newborn brain.
An opposite effect was observed in liver, where p,p’-DDT in-
creased and o,p’-DDT decreased luciferase, thus indicating
that these compounds modulate ER activity in adult and new-
born tissues by use of a similar mechanism.
The ERE-tkLUC mouse proves to be a suitable tool to
functionally assess the tissue specificity of estrogenic/anti-
estrogenic compounds in adult (as well as in suckling) mice.
(Endocrinology 143: 4544–4551, 2002)
ORGANOCHLORINE PESTICIDES COMPOSE a largefamily of chemicals that are toxic for endocrine functions
(1–6). The use of these compounds has been banned or severely
restricted in most industrialized countries (7). However, be-
cause of their persistence in the environment and in living
organisms, they still represent a largely unsolved problem for
human health (8–12). Studies carried out over the last decade
documented that these xenohormones bind to and activate the
estrogen receptors (ERs) and, consequently, induce estrogenic
effects in different animals. It is now clear that these com-
pounds, also named endocrine disrupters (EDs), are able to
evocate an endocrine response at the level of tissues target of sex
steroids, thyroid, and adrenal hormones (13–15). This has been
shown in vitro using cell lines engineered to overexpress specific
receptors and reporter genes (16, 17) and in vivo with specific
animal models in which some of the aspects of the pathophys-
iological action of these compounds have been illustrated (18–
20). The recent recognition of the multifaceted activities of es-
trogen and its receptors reveals new potential targets for the
activity of EDs. This, together with the novel acquired knowl-
edge that, in the context of different tissues, a given ligand may
have even opposite activity (e.g. agonist or antagonist) on ERs,
imposes evaluation of the potential hazard of ER-interacting
chemicals by the analysis of their effects on the transcriptional
activity of ER in each specific target organ. The animal models
applied to date to the study of the in vivo effects of organo-
chlorine pesticides (21–23) do not allow us to investigate the
toxicodynamic and toxicokinetic properties of these com-
pounds in the whole organism and, in particular, in the non-
reproductive organs. The availability of a novel line of mice
reporter of ER transcriptional activation (ERE-tkLUC; Ref. 24)
prompted us to prove its applicability to the study of EDs by
evaluating the activity of the two isomers composing dichlo-
rodyphenyltrichloroethane (DDT), a well-known weak envi-
ronmental estrogen. We here provide a map of ER activation by
the two DDT isomers, p,p’-DDT and o,p’-DDT in nonrepro-
ductive tissues and prostate and demonstrate that these two
compounds may either block or activate this receptor transcrip-
tional activity, depending on the tissue targeted. In addition,
because of the high concern regarding the effective exposure of
the newborn to chemicals through the mother’s milk (25), we
used our system to assess the extent of ER activation in tissues
of suckling newborns breast-fed by DDT-exposed mothers.
Materials and Methods
Experimental animals
The procedures involving the animals and their care were conducted
in accord with institutional guidelines, which comply with national and
Abbreviations: CNS, Central nervous system; DDT, dichlorody-
phenyltrichloroethane; 17-E2, 17-estradiol; ED, endocrine disrupter;
ER, estrogen receptor; ERE, estrogen-responsive element; GC, gas chro-
matography; LUC, luciferase; MS, mass spectrometry analysis; PR, pro-
gesterone receptor; tk, thymidine kinase.
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international laws and policies (National Institutes of Health, Guide for
the Care and Use of Laboratory Animals, 1996, 7th ed. Washington, D.C.;
National Academy Press, National Research Council Guide, www.nap.
edu/readingroom/books/labrats).
ERE-tkLUC transgenic mice were kept in animal rooms maintained
at a temperature of 23 C, with natural light/dark cycles. For the exper-
iments, we used heterozygous littermates obtained by mating our
founders with C57BL/6 wild-type mice. Heterozygous transgenic male
mice were screened by PCR analysis for the presence of the transgenic
cluster.
Heterozygous male mice (2 months old) were injected ip with 100 l
17-E2, p,p’-DDT or o,p’-DDT at the needed concentration or with 100
l of vehicle (vegetal oil) as control. At the time of death of the animals,
by cervical dislocation, the tissues were dissected and immediately
frozen on dry ice. Tissue extracts were prepared by homogenization in
500 l of 100-mm K2PO4 lysis buffer (pH 7.8) containing 1 mm dithio-
threitol, 4 mm EGTA, 4 mm EDTA, and 0.7 mm phenylmethylsulfo-
nylfluoride, with three cycles of freezing-thawing and 30 min of mi-
crofuge centrifugation at maximum speed. Supernatants, containing
luciferase, were collected, and protein concentration was determined by
Bradford’s assay (26).
Chemicals
We purchased 17-estradiol (17-E2) from Sigma (Pomezia, Italy).
Radioligands for progesterone receptors (PRs) were purchased from
Amersham (Milan, Italy). Organochlorine compounds p,p’-DDT [1,1,1,-
trichloro-2,2-bis(p-chlorophenyl)ethane] and o,p’-DDT [1,1,1,-trichloro-
2(p-chlorophenyl)-2-(o-chlorophenyl)ethane] were purchased from
Superchrom (Milan, Italy). ICI 182,780 was a gift from Zeneca Pharma-
ceuticals (Cheshire, UK).
Enzymatic assay
Luciferase enzymatic activity was measured, as reported by de Vet
et al. (27), in tissue extracts at a protein concentration of 1 mg/ml. The
light intensity was measured with a luminometer (Murex Diagnostici,
Rome, Italy) over 10 sec and expressed as relative light units per mi-
crogram proteins.
Ligand-binding assays
The PR concentration in the cytosols from liver was measured by the
charcoal-dextran method, at a protein concentration between 1 and 2
mg/ml, and carried out by means of the multiple-saturation analysis
(range of 3H-ORG2058: 0.75–12 nm) in the presence or absence of a
100-fold excess of cold progesterone as competitor. The values were
plotted by the method of Scatchard (28). Proteins in cytosol were de-
termined by the method of Bradford (26).
Gas chromatography-mass spectrometry (GC-MS) analysis
Sample extraction. One hundred microliters of serum or 40 mg of milk
were extracted with n-hexane/diethylether, 1:1 (vol/vol), mixture and
eluted on a Florisil cartridge (6 ml, 1 g; Supelco, Bellefonte, PA) and a
silica cartridge (6 ml, 1 g; Supelco) sequentially. The extracts were
brought to dryness, and the derivatives were dissolved in n-hexane
(100 l).
GC-MS analysis. Two microliters of the extracts were injected in GC-MS.
Then, p,p’-DDT was separated by chromatography on a PONA fused
silica capillary column (Hewlett-Packard, Palo Alto, CA) with helium as
carrier gas (flow-rate, 1 ml/min constant flow) and by temperature
programming. The instrument used was a GC HP 6890 MS HP 5972-A
(Hewlett-Packard); p,p’-DDT was identified by 235 and 237 ions and
quantified by the standard addition method (10- and 100-ng/ml solu-
tions). The concentrations are expressed as ng/ml or ng/gmilk fat.
Statistical analysis
P values were calculated with ANOVA followed by the Scheffe´ test.
Results
Tissue-specific modulation of transgene expression
by p,p’-DDT
To determine the activity of the DDT isomer p,p’-DDT on
ER, in the context of specific tissues, male mice were treated
with p,p’-DDT using a route of administration (ip) and a
dosage known, by preceding studies carried out in vivo, to be
active on ER. In parallel, mice were also treated with 17-E2
as a reference compound. Figure 1 shows that p,p’-DDT and
17-E2 induced luciferase activity in liver, brain, prostate,
and thymus but not in heart. The p,p’-DDT was also unable
to induce luciferase in lung, an organ clearly responsive to
the treatment with estradiol. With p,p’-DDT, the strongest
luciferase induction was observed in liver (10-fold induc-
tion). In the other responsive organs, luciferase content was
generally doubled, with respect to time 0 and to controls
(brain and thymus, 2-fold induction; prostate, 1.6-fold in-
duction). Interestingly, with p,p’-DDT, the peak of luciferase
accumulation was observed 16 h after treatment. With 17-
E2, this effect was obtained 6 h after injection. Therefore, the
ER response to p,p’-DDT seemed to be delayed, with respect
to 17-E2. Measurement of luciferase content at 6, 16, and
24 h of animals treated with vehicle demonstrated that the
basal activity of the promoter is very stable in time.
At the dosage selected for the study, the extent of luciferase
accumulation was always lower with p,p’-DDT than with
estradiol administration. To investigate whether this was
attributable to a different intrinsic activity of the two com-
pounds or to the dosage used, we proceeded to compare the
effects of estradiol and p,p’-DDT using a large range of
concentrations. In all the tissues investigated, p,p’-DDT was
maximally active at a dosage 100 times higher (5000 g/kg)
than that of 17-E2 (50 g/kg) (Fig. 2, A and B). Thus, in
agreement with the previous observations, in all the tissues
assayed, perhaps with the exception of brain, the intrinsic
activity of p,p’-DDT never approached that of 17-E2.
Luciferase activity reflects the effects of 17-E2 and
p,p’-DDT on an endogenous target gene, PR
To verify whether the modulation of the transgenic marker
by 17-E2 and p,p’-DDT mirrored that of an endogenous
estrogen target gene, we measured PR binding in liver after
the dose- and time-dependency treatments (Fig. 3). PR con-
tent, as measured by radioligand assay, was maximal at 6 and
16 h after 17-E2 or p,p’-DDT injection, respectively. The
doses determining the maximal response were 50 and 5000
g/kg for the two compounds (Fig. 3A). In agreement with
the observations on the effects of the two compounds on
luciferase, 17-E2 intrinsic activity was significantly higher,
with an induction of PR of 20-fold vs. the 12-fold observed
with p,p’-DDT. The basal levels of PR were undetectable at
different time points (not shown). The measurement by im-
munoenzymatic assay of PR content in liver of mice treated
for 0, 6, and 16 h with p,p’-DDT or 17-E2 confirmed the
results obtained by binding (not shown).
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p,p’-DDT activity requires ER
Previous studies on DDT isomers and metabolites have
questioned whether the less estrogenic DDT isomer p,p’-
DDT was really acting through ERs (17, 29), or better via
aromatase induction of its major metabolite p,p’-DDE (30) or
by stimulating growth factor receptor tyrosine kinase activity
FIG. 1. 17-E2 and p,p’-DDT effects on luciferase expression in ERE-tkLUC mice. Two-month-old mice were fed an estrogen-free diet for 2 d
before treatments. Vegetal oil (shaded bars) or an oil solution of p,p’-DDT (5000 g/kg) (A, clear bars) or 17-E2 (50 g/kg) (B, clear bars) were
administered ip at time 0. Controls (vehicle-treated animals) at defined time points are indicated as shaded bars. Animals were killed at the
indicated time-points, and tissues were dissected and stored at 80 C until assayed. Luciferase activity, measured in tissue extracts, was
expressed as relative light units normalized on protein concentration. The experiments were repeated five times, with a total of nine animals
per group. Bars represent the average  SEM. *, P  0.05, as compared with the control.
FIG. 2. Dose response analysis. ERE-tkLUC mice were treated ip with oil; with p,p’-DDT at the doses of 50, 500, 5,000, 50,000, and 500,000
g/kg; or 17-E2 at the doses of 0.5, 5, 50, and 500g/kg for 16 or 6 h, respectively. Luciferase activity was determined as specified in the previous
figure. The experiments were repeated three times, with a total of six animals per group; data represent the mean of all the experiments done.
Values are plotted on a logarithmic scale.
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(31). Thus, to assess whether the described effects of p,p’-
DDT on the ERE-luciferase transgene were mediated by the
ER, 2-month-old male mice were treated with the compound
together with the selective ER antagonist ICI-182,780. To
ensure the blockade of ER, ICI-182,780 was injected at the
dose of 20 mg/kg, 1 h before (10 mg/kg) and 6 h after (10
mg/kg) p,p’-DDT (at the dose of 5000 g/kg). Luciferase
activity was measured in liver, brain, prostate, and thymus,
16 h after injection of p,p’-DDT. As shown in Fig. 4, the
induction of the reporter was efficiently blocked by ICI-
182,780 in all the tissues analyzed. ICI-182,780 alone did not
elicit any significant effect, suggesting its lack of toxicity on
the system. These data indicate that p,p’-DDT activity in
these tissues requires ER.
o,p’-DDT isomer displays an antagonist activity on the
liver ERs
p,p’-DDT represents the most abundant isomer (80%) of
the technical grade DDT. We then tested also the activity
of the less abundant, but more estrogenic o,p’-DDT. In all
the tissues tested, except the liver, o,p’-DDT induced max-
imal luciferase accumulation 16 h after treatment (Fig. 5A).
As observed with the p,p’-DDT isomer, the maximal effect
was at the dose of 5000 g/kg (not shown). Interestingly,
at the same concentrations used to activate the reporter in
the brain, thymus, and prostate, o,p’-DDT inhibited lucif-
erase accumulation in the liver. To assess whether the
decreased transgene expression observed in liver was at-
tributable to trans-repression or blockade of ER activity,
FIG. 3. Effect of p,p’-DDT administration on progesterone receptors in ERE-tkLUC mice liver. Mice were treated as specified in Figs. 1 and
2; doses of 17-E2 (open bars) or p,p’-DDT (shaded bars) are plotted on a logarithmic scale. PR binding was measured in cytosol of mouse liver,
by the charcoal-dextran method, using [3H]ORG2058 as radioligand and progesterone as cold competitor. Values are expressed as femtomoles
per milligram of cytosolic protein. Bars represent the average  SEM of two individual experiments, each performed in triplicate. *, P  0.05,
as compared with the control. prot., Protein.
FIG. 4. p.p’-DDT induction of luciferase expression is
blocked by the ER-specific antagonist ICI-182,780. A total
of 10 mg/kg ICI-182,780 was injected ip, 1 h before and 6 h
after a single dose of p,p’-DDT (5000 g/kg). Mice were
killed 16 h after p,p’-DDT administration. Luciferase ac-
tivity was normalized for protein content; fold induction
was calculated with respect to values measured in control
mice (oil-injected). The graph represents the data average
of three separate experiments, each performed on groups of
two mice each. *, P  0.05 vs. p,p’-DDT-treated mice.
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we treated adult male mice with either a fixed amount of
17-E2 (50 g/kg) alone or with increasing doses of o,p’-
DDT or p,p’-DDT for 16 h. Figure 5B shows that the co-
administration of 17-E2 and o,p’-DDT resulted in a sig-
nificant decreased luciferase activity in liver, but not in
brain, where the presence of the o,p’-DDT isomer in-
creased the natural hormone effect.
Activity of ER in 4-d-old mice nursed by p,p’-DDT- and
o,p’-DDT-treated mothers
Because exposure to DDT has been shown to be particu-
larly critical during perinatal life (23, 32, 33) and because
DDT contaminates milk (5, 25, 34, 35), we used the ERE-
tkLUC model to investigate whether DDT was activating ERs
FIG. 5. o,p’-DDT activates ER transcriptional activity in all the tissues but not in liver. A, Adult mice were injected with oil or an oil solution
of o,p’-DDT at increasing concentrations (50–500 to 5,000–50,000 g/kg). Mice were killed 16 h after treatment. B, Competition experiments
of the DDT isomers with 17-E2. Two-month-old mice, fed with an estrogen-free diet for 2 d before treatments, were injected ip with 17-E2
(50 g/kg) alone or with four concentrations of p,p’-DDT or o,p’-DDT (50–500 to 5,000–50,000 g/kg). Controls were injected with vegetal oil.
Luciferase activity was measured in liver and brain of mice killed 16 h after treatment. Doses of p,p’-DDT and o,p’-DDT are plotted on a
logarithmic scale. The experiments were repeated three times, with a total of six animals per group. Bars represent the average  SEM of two
individual experiments, each performed in triplicate. *, P  0.05, as compared with the control.
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in newborns breast-fed by mothers exposed to this com-
pound. Lactating transgenic mothers were given a single ip
injection of p,p’-DDT or o,p’-DDT (50 mg/kg body weight)
at d 4 after delivery. Suckling pups were killed 16 h after
treatment of the mothers, and luciferase activity was mea-
sured in their livers and brains. The amount of milk the pups
had sucked was hypothesized by weighing the stomachs. In
pups nursed by the DDT-treated mothers, the stomach
weighed 40% less than controls. Despite that, the amount of
DDT in the milk was sufficient to modulate ERs, as shown
by luciferase enzymatic activity (Fig. 6). Treatment of the
lactating mothers with both DDT isomers resulted in an
increase of luciferase activity in the pups’ brains. In liver, the
effect of the two isomers reflected what was already de-
scribed in adult mice: p,p’-DDT caused an increase, and
o,p’-DDT caused a decrease, of luciferase activity, although
with a different magnitude than with the adults. To assess
whether these differences in reporter induction could be
ascribed to lower levels of circulating DDT in pups, p,p’-DDT
was measured in serum of lactating mothers and suckling
mice and in milk, by GC-MS, at the time point showing
maximal induction. In animals treated with vehicle, p,p’-
DDT was undetectable. In the serum of lactating mice, we
measured an average of 1,460  266 ng/ml, 16 h after in-
jection. Interestingly, at the same time-point, the concentra-
tion of p,p’-DDT in milk was significantly higher than in
serum (53,790  3,550 ng/g milk fat). In the serum of pups,
p,p’-DDT content was of 208 19 ng/ml (Table 1). As shown
in Fig. 6, this p,p’-DDT concentration was sufficient to acti-
vate the reporter, both in liver and brain. These results show
that, in suckling newborns, reporter activity is regulated by
concentrations of p,p’-DDT similar to those often reported in
serum of humans in exposed populations (36).
Discussion
By the use of a novel reporter mouse, we here provide
evidence of the activity of p,p’-DDT and o,p’-DDT in mouse
nonreproductive tissues and prostate. Our data demonstrate
a differential isomer-specific activity in liver but not in all the
other organs tested. We also show that this isomer-specific
effect can be observed in newborn mice lactating from a
mother exposed to DDT.
The present study demonstrates, for the first time, that
DDT isomers modulate ER activity in nonreproductive or-
gans, such as liver, brain, and thymus. So far, little is known
with regard to the effects of these compounds in nonrepro-
ductive organs. Previous epidemiological studies have
shown effects of DDT on liver and the central nervous system
(CNS) (8, 10). Toxicity in liver has also been experimentally
reproduced by Takayama et al. (11) in nonhuman primates.
The experimental data on the effects on the CNS in vivo are
few (33, 37) and relate to the altered behavior of the exposed
animals. Our data provide the basis for the understanding of
the mechanism of toxicity of these compounds in liver and
CNS. Furthermore, by showing an effect in prostate, and
particularly in thymus, our findings suggest novel sites for
potential toxic effects of DDT. This observation is worth
pursuing in more detailed experimental or epidemiological
studies.
In this initial systematic analysis of the effects of DDT
isomers on ERs in vivo, two observations need to be under-
lined. First, both isomers were inactive in lung, a tissue
known to express ER and clearly responsive to 17-E2.
Second, in liver, the two isomers display opposite effects,
p,p’-DDT being an ER agonist, and o,p’-DDT an ER antag-
onist. Liver is known to express predominantly ER,
whereas lung expresses ER. These observations lead us to
hypothesize that DDT is inactive in tissues expressing only
ER and may have a differential effect when only ER is
expressed. Supporting this hypothesis is the fact that also in
prostate, an organ with predominant expression of ER, the
luciferase induction by DDT is weaker than in the other
responsive tissues. This might have important implications
for the evaluation of the toxicity profile of different organo-
chlorine pesticides. Remaining unclear is the significance of
the delayed response of ERs to DDT; the maximal luciferase
and PR response was in fact observed at 6 and 16 h after
injection of 17-E2 and DDT, respectively. This could be
attributable to a slower kinetic of distribution of DDT iso-
mers from the site of injection.
FIG. 6. Effects of DDT isomers in the suckling mice. Lactating moth-
ers, maintained on a normal diet, were injected with 50 mg/kg body
weight of p,p’-DDT, o,p’-DDT or vehicle as control. Mothers were
treated at d 4 after delivery, and pups were killed 16 h later. Lucif-
erase activity was normalized to protein content and monitored in
liver and brain of the newborn. Each column is the mean SEM of five
mice/group from two separate experiments. *, P  0,05, compared
with the appropriate control.
TABLE 1. Levels of p,p-DDT in milk and serum of adult and
suckling mice
Treatment
Lactating mother Suckling mice
Serum (ng/ml) Milk (ng/g fat) Serum (ng/ml)
Control n.d. n.d. n.d.
p,p-DDT 1,460  266 53,790  3,550 208  19
n.d., Not detected. Data represent the mean SEM of two individual
experiments, each on three animals.
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The data here presented demonstrate that the reporter mouse
we used is a very promising system for acquiring a global
perspective of ED activity in a mammalian organism. As de-
scribed in the previous publication (24), and here with the
analysis of estrogen and DDT effects on an endogenous target
for estrogens (PR), the measure of luciferase seems to fully
reflect the activity of ERs in vivo. The present ERE-tkLUC mouse
can only allow monitoring of the sum of ER and ER tran-
scriptional activities. Novel models obtained by breeding the
ERE-tkLUC mice into ER and ER knockout mice, will enable
the study of the effects on each ER receptor subtype.
Recently, Nagel et al. (38) also proposed the use of reporter
mice in the study of the effects of xenobiotics. This model,
however, has several advantages, with respect to Nagel’s.
In fact, the presence of insulator sequences surrounding the
reporter element prevents position effects and ensures
the expression and full responsiveness of the reporter in all
the mouse cells. Furthermore, the choice of luciferase as reporter
grants a dynamic analysis of the state of ER activity. This is
because the wild-type luciferase has proven to have a fast turn-
over when expressed in mammalian tissues (half-life of 2–3 h).
Finally, luciferase activity can be monitored in vivo by photon
imaging. This enables one to obtain a global, whole-body view
of the state of ER activity in time, within the same animal.
When using a reporter mouse, the major concern regards
the limited sensitivity of the animal system. Indeed, in the
ERE-tkLUC mouse, the induction of luciferase was triggered
at DDT isomer concentrations almost one order of magnitude
lower than those necessary to induce the uterotropic effect in
prepuberal female mice (18, 39). We also show that o,p’-DDT,
at a dose known to interfere with animal fertility (50 g/kg),
significantly affects ER response. In female mice with a single
injection of 50,000 g/kg DDT, we reached serum concen-
trations similar to those reported in exposed populations (25,
36, 40); and at that dosage, the effect of the toxic compound
on luciferase is very strong.
Most interesting are the data on suckling mice. In these
mice, breast fed by DDT-exposed mothers, we measured a
blood concentration of the toxic agent (208 ng/ml) similar to
values of DDT and other organochlorine compounds [poly-
chlorinated biphenyls (PCBs)] found in blood of peoples
living in industrialized areas (25, 36). This would indicate
that the model is adequate for studies on the activity of
xenobiotics concentrations comparable with those found in
environmentally exposed individuals. The possibility of fol-
lowing the effects of DDT during development and lactation
in all the mouse tissues will finally provide functional data
on the effects of pesticides on reproductive and nonrepro-
ductive organs, still incomplete for newborn and juvenile
mammals. Therefore, different from the uterotropic assay,
which is the most used in vivo model so far used for the study
of toxic compounds active on ERs, the model system we
generated has the necessary sensitivity and target specifi-
city to provide information on the tissue-selective agonist/
antagonist effect of EDs.
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